Oral Answers to Questions Debate
Full Debate: Read Full DebateRobin Walker
Main Page: Robin Walker (Conservative - Worcester)Department Debates - View all Robin Walker's debates with the Department for Exiting the European Union
(7 years, 8 months ago)
Commons ChamberThe Department has a wide programme of engagements to ensure that the views of the science and technology sector are heard. For example, we have recently met representatives of the life sciences and tech sectors, and will continue to meet them in the coming months. While it is too early to speculate on our future relationship with EU science and research programmes, as part of our commitment to make Britain the global go-to nation for scientists, innovators and tech investors, we will be investing an extra £2 billion in research and development by the end of this Parliament.
I thank the Minister for that answer. The life sciences and pharma sectors are concerned that they need globally recognised and equivalent regulations to compete internationally. Can the Minister assure me that he will continue to work closely with these sectors to ensure they have the best possible opportunities in the Brexit negotiations?
My hon. and learned Friend is right, and the Government are committed to ensuring a positive outcome for the UK’s life sciences and the pharmaceuticals sector as we exit the European Union. We have welcomed many hundreds of millions of pounds of new investment from Alnylam and GSK, and I can assure her that Ministers in our Department are engaging, and will continue to engage, with the pharma and life sciences industry to ensure that we take the opportunities as well as meet the challenges ahead.
In Europe’s largest space innovation competition this year, the UK took the top prize and four major awards. We have been one of the leaders in, and most successful exploiters of, space technology, and it is vital that this support continues. In particular, can the Minister confirm that the European Space Agency is entirely independent and not an EU organisation, and that our membership of and participation in ESA will continue, as will the UK’s involvement in space research?
Absolutely. The UK space industry, in which I understand my right hon. Friend’s husband has played an important part, is a global success story, leveraging our best talent to deliver highly innovative products and services every year. We want a UK space industry that captures 10% of the global market by 2030, creating 100,000 new jobs. The UK will remain a member of the ESA, which is not a part of the EU. The ESA’s next ministerial council is being held in Lucerne today, attended by my hon. Friend the Minister for Universities, Science, Research and Innovation.
May I thank the Minister for taking time last week to meet me and science and engineering companies from my constituency? Will he heed the calls made at that meeting, specifically to continue the easy and free movement of scientists across Europe and to maintain our participation in European projects?
I am grateful to my hon. Friend for arranging that very useful meeting. I will repeat what the Secretary of State has said before:
“We will always welcome those with the skills, the drive and the expertise to make our nation better still…Britain has always been one of the most tolerant and welcoming places on the face of the earth. It must and it will remain so.”
We are a global leader in scientific collaboration, and we want that to continue.
Is it the Government’s policy to exit the European Medicines Agency at the same time as we exit the EU?
The Government are committed to ensuring a positive outcome for life sciences and pharma as we exit the European Union. The Prime Minister has already outlined steps to make sure that we continue to back research and development. No decisions have yet been taken as to the final location of the European Medicines Agency.
T.G. Eakin, which is located in my constituency, is a successful business that supplies medical equipment throughout the world. It is imperative that such businesses are kept informed of progress. Will the Minister outline how his Department will achieve that?
The absence of a Government plan for the science and technology sector is causing huge uncertainty. The Minister will be aware that the current funding arrangements for the ITER project, which includes a JET—Joint European Torus—centre for fusion energy in the UK, run out in 2018. If he can say nothing else about the Government’s plan, will he confirm that the UK will seek to maintain full participation in the Euratom programme?
My ministerial colleagues and I have met a number of higher education institutions and groups, including Universities UK, the royal academies, the Russell Group and the Universities of Swansea, Reading, Ulster and Strathclyde. The sector strongly supports our ambition to create an environment in which the UK as a whole can continue to be a world leader in research, science and the tertiary education sector.
I thank the Minister for that answer. The University of the West of Scotland provides a high-quality and accessible education, and the university’s 112 staff from the EU are absolutely critical in delivering that. Can the Minister guarantee EU staff working across higher education and further education the right to remain without any visa conditions when the UK leaves the EU?
We value highly the contribution of EU and international researchers and academic staff. We remain fully open to scientists and researchers from across the EU, and we will always welcome those with the skills, drive and expertise to make our nation better still. Regarding those who are already in the UK, we have been clear that there has been no change to the rights and status of EU nationals in the UK as a result of the referendum.
In 2014-15, there were 43,000 EU staff in the UK higher education sector. Those people are making decisions now about their future. When will the Government give them certainty, and what is in the Government’s plan for Brexit to ensure that our universities can benefit from the contribution of those staff members once we have left the EU?
I refer the hon. Gentleman to the answer that I have just given. I think we have been very clear that we want to continue to attract the top talent and that we want the UK to remain a leader in research, which means attracting people from the EU and from around the wider world.
The Erasmus exchange programme has enabled 200,000 UK students and 20,000 staff to spend time abroad. That enhances their employability, improves their knowledge and promotes understanding between cultures. What is the plan to ensure that that kind of valuable exchange can continue in future?
There is no change for those who are currently participating in, or about to start, Erasmus+. Erasmus+ offers a range of programmes to countries across Europe and beyond. Post-exit access to Erasmus+ will be a matter for the negotiations that will follow the triggering of article 50. The Erasmus+ programme has proved to be a valuable tool that helps organisations and citizens to achieve their potential through international education, training and collaborative opportunities. As part of our vision for the UK as a global nation, I am sure we will want to look at how such an approach can be perpetuated in the future.
The Secretary of State was absolutely right to say earlier that we only get one chance at this, so the Prime Minister is absolutely right to make sure that we have listened to all the representations, including those from universities, before invoking article 50. Does he agree that it is far preferable to have a full, hearty Brexit than a rushed, messy, unsatisfactory dog’s breakfast?
The Government fully recognise the contribution that tourism makes to our economy and communities in all parts of the UK. Foreign visitors contribute £22 billion to our economy. There were record numbers of overseas visitors each month from July to September—10.7 million in total. I thank my hon. Friend and neighbour for hosting a roundtable with some of the key players in the hospitality sector, which I attended last week shortly after attending the Tourism Industry Council. As the Prime Minister has said, we are confident that our exit represents opportunities for growth in tourism, and we will work closely with the industry to achieve them.
Major pharmaceutical investors, such as Eli Lilly in my constituency, use a common EU system for medicine regulation in clinical trials to help British patients to gain access to the best treatments in the world. What work is the Minister doing to ensure that the decades-long co-operation with the EU is maintained after Brexit not just for the benefit of companies but for the benefit of patients?
I assure my right hon. Friend that we will be looking very carefully at that. As I said earlier, no decisions have yet been made about the future location of the European Medicines Agency. Until we have left the EU, the UK remains a member with all the rights and obligations that membership entails. The Medicines and Healthcare products Regulatory Agency continues to play a full role in all procedures of the EU medical device regulatory framework.
What priority has the ministerial team given to achieving continued tariff-free access and continued membership of the single market?
Since 2014, Scottish small and medium-sized enterprises have received over €21 million in funding through Horizon 2020. What assurances can the Minister give that firms will be eligible for equivalent funding before and after 2020?
As the hon. Lady knows, the Treasury has already given strong assurances up to 2020, beyond the period of our exiting the EU. That is an important signal to SMEs, universities and others that they should continue bidding for the scheme. The current EU budget and the framework for Horizon 2020 runs only up to 2020.
On the principle of humanitarian assistance to the involuntarily delayed, I call Mr Henry Smith.